|
|
|
|
|
|
|
|
|
|
Autologous CAR T-cell therapy offers enormous potential, but patient-specific manufacturing presents challenges in turnaround time, quality, scalability, and technology transfer. In this Cell & Gene Live on Oct. 15, 2026 at 11 AM ET, Mayo Clinic experts will share practical insights on overcoming production bottlenecks, strengthening quality-focused processes, partnering with CDMOs, evaluating alternative platforms, and making early CMC decisions that support clinical execution and commercial readiness. Registration is free.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reducing Inventory Errors In Clinical Trials
|
|
White Paper | By Rachel Aletti, McCreadie Group
|
Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.
|
|
|
|
|
|
|
|
|
The Advanced Therapies Congress USA is America's largest commercial cell and gene therapy conference and exhibition. The event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. Join us in Boston for 2026! Use code LSC20 for 20% off. Book your ticket now.
|
|
|
|
CLINICAL TRIALS SOLUTIONS
|
|
|
|
|
|
|
|
|
|
By Jose Saiz de Omeñaca
|
Nearly all the industry's emissions happen upstream from core manufacturing functions. This puts sustainability almost entirely on the shoulders of purchasing.
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
